Article

Potential causal links between genetic variants in<i>SAMM50</i>,<i>SUGP1</i>,<i>MAU2</i>, and<i>GATAD2A</i>and liver fat in individuals with normal weight

2024-11-05

Abstract excerpt

<h4>Background & Aims</h4> Metabolic-associated steatotic liver disease (MASLD) affects individuals across a range of body weights, but little is known about the genetic determinants of this condition in individuals with normal BMI. This study aimed to identify genetic variants contributing to hepatic fat levels in normal-weight individuals. <h4>Methods</h4> We conducted a genome-wide association study (GWAS) usin...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 0ede22c5-88f7-5e9a-a27d-3ed9831b6965
DOI: 10.1101/2024.11.05.24316758

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Potential causal links between genetic variants in<i>SAMM50</i>,<i>SUGP1</i>,<i>MAU2</i>, and<i>GATAD2A</i>and liver fat in individuals with normal weightDOI 10.1101/2024.11.05.24316758Read

Genome-wide Studies Reveal Genetic Risk Factors for Hepatic Fat Content.Semantic proximity Read

Unravelling genetic susceptibility and causal factors in liver health using MRI quantification of inflammation, fat and iron in the liver.Semantic proximity Read

Trans-ancestral rare variant association study with machine learning-based phenotyping for metabolic dysfunction-associated steatotic liver disease.Semantic proximity Read

Machine learning enables new insights into clinical significance of and genetic contributions to liver fat accumulationSemantic proximity Read

Machine learning enables new insights into genetic contributions to liver fat accumulationSemantic proximity Read

Development of a Polygenic Risk Score for Metabolic Dysfunction-Associated Steatotic Liver Disease Prediction in UK BiobankSemantic proximity Read

Genome-wide interaction study with body mass index identifies CYP7A1 and GIPR as genetic modulators of metabolic dysfunction-associated steatotic liver disease.Semantic proximity Read

Unraveling Mechanisms of Genetic Risks in Metabolic Dysfunction-Associated Steatotic Liver Diseases: A Pathway to Precision Medicine.Semantic proximity Read

Genetic Risk Factors for Metabolic Dysfunction-Associated Steatotic Liver Disease.Semantic proximity Read

Genome-wide and Mendelian randomisation studies of liver MRI yield insights into the pathogenesis of steatohepatitis.Semantic proximity Read

Genetic insights of waist-to-height ratio on the risk of steatotic and advanced liver diseases: genome-wide association study and polygenic risk score-based analyses.Semantic proximity Read

Profiling the genome and proteome of metabolic dysfunction-associated steatotic liver disease identifies potential therapeutic targetsSemantic proximity Read